Actively Recruiting
Clonal Architecture of ASXL1-mutated Myelofibrosis
Led by University Hospital, Angers · Updated on 2026-03-09
50
Participants Needed
13
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective study to decipher the clonal architecture of ASXL1-mutated primary and secondary myelofibrosis and its impact on prognosis
CONDITIONS
Official Title
Clonal Architecture of ASXL1-mutated Myelofibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Affiliated with the national social security system
- Diagnosed with ASXL1 mutated primary or secondary myelofibrosis
- Signed consent to participate in the study
- Included or willing to be included in the national clinical-biological database of France Intergroupe Syndrome Myéloprolifératifs (FIM)
You will not qualify if you...
- Having another active hematological disease or cancer at the time of diagnosis
- Being under a legal protection scheme or unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
CHU Angers
Angers, France
Actively Recruiting
2
CHRU Brest
Brest, France
Not Yet Recruiting
3
CH Cholet
Cholet, France
Not Yet Recruiting
4
CHU Henri MONDOR
Créteil, France, 94010
Actively Recruiting
5
Institut Paoli Calmettes
Marseille, France, 13009
Actively Recruiting
6
CHU Nantes
Nantes, France
Not Yet Recruiting
7
AP-HP Hôpital Saint Louis
Paris, France, 75010
Not Yet Recruiting
8
Hôpital Bicêtre
Paris, France
Actively Recruiting
9
CHU de Bordeaux
Pessac, France, 33604
Actively Recruiting
10
CHU Lyon
Pierre-Bénite, France, 69495
Actively Recruiting
11
CH de Cornouaille
Quimper, France
Not Yet Recruiting
12
CHRU Tours - Hôpital Bretonneau
Tours, France
Actively Recruiting
13
CH de Vannes
Vannes, France
Not Yet Recruiting
Research Team
M
Margaux Wiber, PharmD.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here